Low-dose allopurinol in the treatment of cutaneous sarcoidosis: Response in four of seven patients

Journal of Dermatological Treatment

Volumn 16, Issue 2, 2005, Pages 125-127

  Bregnhoej, Anne ^a,b   Jemec, G B E ^a  

^a ROSKILDE HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; HYDROXYCHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; PURINE P2X7 RECEPTOR; STEROID;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SARCOIDOSIS; SKIN DISEASE; TREATMENT OUTCOME;

ADULT; ALLOPURINOL; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; SKIN DISEASES;

EID: 18744396110     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630510027886     Document Type: Letter

References (14)

1. Rosof BM. Allopurinol for sarcoid? N Engl J Med. 1976;294:447.
2. Brechtel B, Haas N, Henz BM, Kolde G. Allopurinol: A therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol. 1996;135:307-9.
3. Pollock JL. Sarcoidosis responding to allopurinol. Arch Dermatol. 1980;116:273-4.
4. Pfau A, Stolz W, Karrer S, Szeimies RM, Landthaler M. Allopurinol in der Behandlung der Kutanen Sarkoidose. Hautarzt. 1998;49:216-18.
5. Samuel M, Allen GE, McMillan SC, Burrows D, Corbett JR, Beare JM. Sarcoidosis: initial results on six patients treated with allopurinol. Br J Dermatol. 1984;111:20.
6. Voelter-Mahlknecht S, Benez A, Metzger S, Fierlbeck G. Treatment of subcutaneous sarcoidosis with allopurinol. Arch Dermatol. 1999;135:1560-1.
7. El-Euch D, Mokni M, Trojjet S, Khouaja A, Ben Osman A. Sarcoidosis in a child treated succesfully with allopurinol. Br J Dermatol. 1999;140:1184-5.
8. Antony F, Layton AM. A case of cutaneous acral sarcoidosis with response to allopurinol. Br J Dermatol. 2000;142:1052-3.
9. Fanburg BL. Drug therapy reviews: Treatment of sarcoidosis. Am J Hosp Pharm. 1979;36:351-4.
10. Kerdel FA, Moschella SL. Sarcoidosis, an updated review. J Am Acad Dermatol. 1984;1:1-16.
11. Gawkrodger DJ. Sarcoidosis. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook/Wilkinson/Ebling: Textbook of dermatology. Vol 3. 6th ed. Boston: Blackwell Science. 1998. P. 2679-702.
12. Siltzbach LE. Sarcoidosis: Clinical features and management. Med Clin North Am. 1967;51:483-502.
13. Mizuno K, Okamoto H, Horio T. Monocyte-derived multinucleated giant cells and sarcoidosis. J Dermatol Sci. 2003;31:119-28.
14. Mizuno K, Okamoto H, Horio T. Inhibitory influences of xanthine oxidase inhibitor and angiotensin 1-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors. Br J Dermatol. 2004;150:205-10.